• 3X (DYKDDDDK) Peptide: Advanced Tagging for Protein Workflow

  2026-04-17

  The 3X (DYKDDDDK) Peptide streamlines affinity purification and ultrasensitive immunodetection of recombinant proteins—outperforming traditional tags in both yield and workflow flexibility. Its unique hydrophilic, trimeric design enables reliable results even in challenging metal-dependent and crystallization assays.

• Gemcitabine in Translational Cancer Research: Mechanism, Pro

  2026-04-16

  This article delivers a deep-dive into the mechanistic underpinnings and translational applications of Gemcitabine—4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one—as a DNA synthesis inhibitor for advanced cancer research. We integrate recent mechanistic insights, protocol guidance, and competitive landscape analysis, contextualized by emerging evidence on cancer stem cell signaling. With actionable recommendations and a forward-thinking outlook, this piece guides translational researchers in maximizing Gemcitabine’s impact across apoptosis and DNA damage response assays.

• Tacrine Hydrochloride Hydrate: Mechanism, Evidence & Workflo

  2026-04-15

  Tacrine hydrochloride hydrate (Tetrahydroaminacrine) is a benchmark acetylcholinesterase inhibitor for Alzheimer's disease research. Its dual-site inhibition, solubility, and neuroprotective profile underpin its continued relevance in neurodegenerative disease modeling. Despite clinical withdrawal, it remains a standard for in vitro workflows, as supplied by APExBIO.

• KPT-330 (Selinexor): Applied Oncology Workflows & Troublesho

  2026-04-14

  KPT-330 (Selinexor) enables precise inhibition of CRM1, empowering cancer researchers to induce apoptosis and block tumor proliferation in resistant models. This article delivers optimized protocols, troubleshooting strategies, and translational insights—drawing from landmark studies and APExBIO’s trusted supply—for advanced cancer research applications.

• Lenalidomide (CC-5013): Mechanistic Benchmarks and Research

  2026-04-13

  Lenalidomide (CC-5013) is a potent oral thalidomide derivative and immune system activation agent with verified anti-myeloma and immunomodulatory effects. This article details its molecular mechanisms, experimental benchmarks, and integration into multiple myeloma research, enabling reproducible and targeted workflows.

• Sodium Overload Drives Mitochondrial Dysfunction in NECSO Ce

  2026-04-13

  Qiao et al. (2025) elucidate how sodium influx through TRPM4 channels impairs mitochondrial energy metabolism, triggering a necrotic cell death pathway (NECSO). Their work details the mechanisms by which Na+ overload disrupts ion homeostasis, mitochondrial function, and cell survival—providing a foundational mechanistic advance relevant to apoptosis and disease research.

• CX-5461: Applied Protocols for RNA Polymerase I Inhibition i

  2026-04-12

  CX-5461, a potent RNA polymerase I inhibitor, offers a targeted approach for investigating ribosome biogenesis and solid tumor response. This article delivers workflow-focused guidance, troubleshooting insights, and evidence-based protocol parameters for leveraging CX-5461 in advanced cancer models.

• Applied Workflows with Dronedarone (Multaq) in Arrhythmia Re

  2026-04-12

  Dronedarone (Multaq) from APExBIO empowers advanced and reproducible workflows in cardiac arrhythmia research by offering high purity, robust solubility, and consistent pharmacological activity. This guide translates cutting-edge findings and product attributes into actionable protocols, troubleshooting strategies, and comparative insights for atrial fibrillation and flutter studies.

• YM-155 Hydrochloride: Precision Survivin Inhibitor Workflows

  2026-04-11

  YM-155 hydrochloride stands out as a potent, highly selective survivin inhibitor for cancer research, empowering robust apoptosis assays and advanced xenograft models. This guide unpacks applied workflows, troubleshooting, and evidence-driven protocol enhancements for maximizing reproducibility and scientific insight.

• G418 Sulfate (Geneticin): Precision Selection and Antiviral

  2026-04-11

  G418 Sulfate (Geneticin) stands apart as both a gold-standard selection antibiotic for stable cell line generation and a potent antiviral agent, including activity against Dengue virus. This guide delivers actionable workflows, troubleshooting strategies, and data-driven insights for optimizing G418 use in advanced genetic engineering and virology research.

• Olanzapine: Technical Guidance for Neuroscience and Oncology

  2026-04-10

  Olanzapine (SKU B2240) is a high-affinity antagonist of 5-HT2A serotonin and dopamine D2 receptors, widely used to modulate dopaminergic and serotonergic signaling in neuroscience and glioblastoma studies. It is specifically suited for applications requiring precise receptor antagonism or investigation of glioblastoma cell proliferation inhibition. Use outside these validated research areas is not recommended due to limited evidence.

• Optimizing High-Throughput Cancer Research with Discovery...

  2026-04-10

  This article provides scenario-driven, evidence-based guidance on overcoming common challenges in cell-based anti-cancer screening using the DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023). By addressing experimental design, protocol optimization, and data interpretation, it demonstrates how SKU L1023 streamlines workflows, enhances reproducibility, and accelerates biomarker-driven discovery in cancer research.

• AZ505 and the New Era of SMYD2 Inhibition: Mechanistic In...

  2026-04-09

  AZ505, a potent and selective SMYD2 inhibitor, is catalyzing a paradigm shift in translational epigenetics. This thought-leadership article elucidates the mechanistic underpinnings and experimental breakthroughs of substrate-competitive SMYD2 inhibition, situates AZ505 within the competitive landscape, and presents actionable strategies for translational scientists pursuing high-impact research in cancer, fibrosis, and beyond. Integrating peer-reviewed evidence and forward-looking perspectives, we chart a course for leveraging AZ505 to unlock novel disease-modifying mechanisms and accelerate the path from bench to bedside.

• Tetrandrine: Benchmark Calcium Channel Blocker for Resear...

  2026-04-08

  Tetrandrine is a well-characterized bioactive alkaloid and calcium channel blocker for research. Its high purity, robust DMSO solubility, and validated pharmacological actions make it a standard for neuroscience, inflammation, and cell signaling studies.

• L1023 Anti-Cancer Compound Library: Transforming High-Thr...

  2026-04-08

  The DiscoveryProbe™ Anti-cancer Compound Library (SKU: L1023) empowers cancer researchers with a robust, validated toolkit for high-throughput screening of anti-cancer agents across key oncogenic pathways. Its unique formulation of 1164 cell-permeable, pathway-diverse compounds—pre-dissolved at 10 mM in DMSO—streamlines assay setup while enabling precision targeting, troubleshooting, and biomarker-driven drug discovery.

15164 records 1/1011 page Next 12345 下5页 Last page